Headache News and Research

Latest Headache News and Research

Pfizer COVID-19 jab side effects likely to be mild to moderate in extremely vulnerable 12-15 year olds

Pfizer COVID-19 jab side effects likely to be mild to moderate in extremely vulnerable 12-15 year olds

FDA approves drug-free stroke rehabilitation system to treat upper extremity motor deficits

FDA approves drug-free stroke rehabilitation system to treat upper extremity motor deficits

Two mRNA vaccines are effective even without post-shot symptoms or prior SARS-CoV-2 infection

Two mRNA vaccines are effective even without post-shot symptoms or prior SARS-CoV-2 infection

Persistence of Anti-PF4 levels in VITT patients four months after AstraZeneca COVID-19 vaccine

Persistence of Anti-PF4 levels in VITT patients four months after AstraZeneca COVID-19 vaccine

As temperatures rise, so do the health risks for California’s farmworkers

As temperatures rise, so do the health risks for California’s farmworkers

Early clinical trial data in for whole virus COVID-19 vaccine candidate

Early clinical trial data in for whole virus COVID-19 vaccine candidate

Obstructive sleep apnea may affect heart health and increase blood pressure in children

Obstructive sleep apnea may affect heart health and increase blood pressure in children

Naive B cells could be useful for predicting vaccination response in immunocompromised

Naive B cells could be useful for predicting vaccination response in immunocompromised

Viral load could not predict transmissibility of SARS-CoV-2, study finds

Viral load could not predict transmissibility of SARS-CoV-2, study finds

FDA approves a new indication for chronic sleep disorder treatment

FDA approves a new indication for chronic sleep disorder treatment

CBD may reduce the adverse effects of anti-seizure drugs in people with epilepsy

CBD may reduce the adverse effects of anti-seizure drugs in people with epilepsy

Long COVID may be due to persistent immune disturbances

Long COVID may be due to persistent immune disturbances

FDA approves an intravenous medication to treat patients with Pompe disease

FDA approves an intravenous medication to treat patients with Pompe disease

Study reports on COVID-19 vaccine-related adverse events in young Japanese population

Study reports on COVID-19 vaccine-related adverse events in young Japanese population

Research reveals undertreatment of headaches in racial and socioeconomic groups

Research reveals undertreatment of headaches in racial and socioeconomic groups

One billion doses of Oxford-AstraZeneca COVID-19 vaccine released

One billion doses of Oxford-AstraZeneca COVID-19 vaccine released

Parts of Lake Tahoe close after chipmunks test positive for plague

Parts of Lake Tahoe close after chipmunks test positive for plague

Intradermal administration of low-dose mRNA COVID-19 vaccine induces strong immune response, study finds

Intradermal administration of low-dose mRNA COVID-19 vaccine induces strong immune response, study finds

Study examined 1,497 full-vaccinated healthcare workers for breakthrough infections

Study examined 1,497 full-vaccinated healthcare workers for breakthrough infections

Phase 1/2 trial results for Nanocovax, protein subunit SARS-CoV-2 vaccine from Vietnam

Phase 1/2 trial results for Nanocovax, protein subunit SARS-CoV-2 vaccine from Vietnam